Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05958199
Title Treatment With NPX267 for Subjects With Solid Tumors Known to Express HHLA-2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NextPoint Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center RECRUITING Baltimore Maryland 21287 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Albert Einstein Medical College Montefiore Medical Center RECRUITING New York New York 10461 United States Details
Sarah Cannon Research Institute Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology-San Antonio RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology-Fairfax RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field